Table 7.
The COX-2 inhibitors candidates from the MFH database found by virtual screening using the related ML models built in this work.
Candidates | Origins | IC50 μM a | SOM HP b | Effects |
---|---|---|---|---|
cmp_A1 | Radix Salviae | 1.74 | 0.91 | Anti-inflammation [25] |
cmp_A2 | Gigeriae Galli Endothelium | 2.69 | 0.82 | |
cmp_A3 | Panax Ginseng | 3.47 | 1 | COX-2 inhibition [24] |
cmp_A4 | Angelica sinensis Radix | 3.69 | 1 | |
cmp_A5 | Jujubae Fructus | 4.24 | 1 | Antibacterial [28] |
cmp_A6 | Atractylodes macrocephala | 4.37 | 0.91 | Anti-inflammation [26] |
cmp_A7 | Lycii Fructus | 4.60 | 0.91 | Anti-inflammation [27] |
cmp_A8 | Fagopyrum esculentum | 5.20 | 0.82 | |
cmp_A9 | Mori Follum | 5.92 | 0.82 | |
cmp_A10 | Glycyrrhiza glabra L. | 6.97 | 1 | Anti-oxidation [29] |
a: the average predicted IC50 values by a series of optimal regression models. b: the percentage of highly active inhibitors mapped to the target molecules in the same position during the self-organized map (SOM) training. It can also be taken as the probability of being predicted by an unsupervised algorithm as a highly active COX-2 inhibitor.